Agencies, 23 October: Bharat Biotech toh dawai bona ekta leading company ase aro tai khan para India laga nejor wadai toh coronavirus nemide naam COVAXIN te bonai ase. Tai khan para Phase I aro II trials toh kamiyaab hoikena kothom korishe aro Phase-III trials toh 26,000 hisha lowa khan ke suru kori ase koise.
Bharat Biotech koise, “Covaxin laga Phase 1 & 2 clinical trials para interim analysis kamiyaab hoikena kothom howa bechide DCGI para Phae 3 clinical trials toh desh laga 25 centres para 26,000 hisha lowa khan ke lobole nemide manishe”.
Covaxin toh BharatBiotech para Indian Council of Medical Research (ICMR) – National Institute of Virology (NIV) logode melikena bona laga ase.
Sources koise, October 2 te city-based vaccine maker para Drug Controller General of India (DCGI) ke Phase 3 lob ole nemide akiya manka thakishe.
July te DCGI para Bharat Biotech ke trial lobole nemide mana thakise.
Add Comment